Position in FTRE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,380,104
-$32,199,694 QoQ
Shares Held
252,665
-87.4% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in FTRE Over Time
Shares Held
Position Value (USD)
Derivatives in FTRE
reported options exposure · as of Dec 31, 2025CallValue
$1,740,525
CallShares
100,900
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,565,450,068 across 341 Biotechnology names. FTRE ranks #236 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in FTRE
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,380,104 | 252,665 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,579,798 | 2,004,626 | Shares | Sole | 2026-02-17 | |
| 2025-12-31 | $1,740,525 | 100,900 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $11,394,028 | 1,353,210 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,599,285 | 1,740,746 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $26,419,111 | 3,499,220 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $373,000 | 20,000 | Call | Sole | 2025-02-14 | |
| 2024-12-31 | $11,521,205 | 617,759 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $8,112,750 | 435,000 | Put | Sole | 2025-02-14 | |
| 2024-09-30 | $2,324,000 | 116,200 | Call | Sole | 2024-11-14 | |
| 2024-06-30 | $654,827 | 28,056 | Shares | Sole | 2024-08-14 | |
| 2024-06-30 | $6,301,800 | 270,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | $1,400,400 | 60,000 | Put | Sole | 2024-08-14 | |
| 2024-03-31 | $4,014,000 | 100,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $401,400 | 10,000 | Put | Sole | 2024-05-15 | |
| 2023-12-31 | $3,815,093 | 109,315 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,805,920 | 308,007 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||